As evidenced by the recent COVID-19 pandemic, rapid development of life saving therapies is more critical than ever. CDOs must focus on innovative approaches to accelerate the product development lifecycle. Standardization of protocol elements, introduction
of an end-to-end process for clinical development standards and the utilization of TransCelerate’s Common Protocol Template (CPT), coupled with the right technology, provide a platform for planning and executing trials more efficiently and
getting products to market faster. In this webinar you will learn:
- What to consider in successfully executing implementation of a digital data flow and how to optimize people, processes, and technology to drive end-to-end operational efficiencies.
- How clinical platform and digital data flow reduces cycle times, improves data quality, and accelerates integration of data sources and the ability to connect data across systems.
- How the Lean Protocol™ process reduces time-to-market for new drugs by driving automation and streamlining data flow from study design through to execution and submission while improving quality and compliance and reducing costs and timelines.
Clinical Operations and Digital Innovation Teams
Chief Standards Officer, Nurocor
Barrie Nelson leads product and standards development for Nurocor, the leading provider of Clinical Metadata Repository solutions. He is passionate about helping the BioPharma industry bring order to clinical data. With more than 20 years’ industry experience across biostatistics, clinical data management, and data standards, before leading foundational standards development for CDISC, and now as a founder of Nurocor, Barrie has a unique perspective on the metadata management challenge facing the BioPharma industry.
Vice President, Process and Technology Optimization, Nurocor
Maria brings more than 20 years’ experience delivering business and IT transformation solutions. She has extensive experience in clinical trial operations and management and is an expert in applying program management, process improvement, innovation, and change management methodologies. Maria has led many large-scale, global initiatives within the pharmaceutical industry that include process optimization and technology improvements, driving operational efficiencies. Her technical experience, background in analytics and process improvement coupled with her ability to bridge disparate organizations and disciplines brings critical value as innovation and data technology play increasingly important role.
Vice President, R&D Advisory, Kinapse & Syneos Health Consulting
Dr. Nicholas Lakin has over 20 years of experience in Life Sciences R&D and has advised on large scale, digital transformation strategies and programs across the drug development lifecycle to some of the world’s largest BioPharma organizations.
He has presented at conferences on subjects from Data Management best practice to machine learning and the future of clinical operations and is recognized as thought leader on digital and technology transformation and implementation. Nicholas
holds an MA and D.Phil from the University of Oxford in Theoretical Chemistry.
Nurocor provides the industry-leading platform for digitized clinical development to help companies bring drugs to market faster. Nurocor provides a set of documented data standards, has defined the Lean Protocol™ Process, and automates the application of these standards and the Lean Protocol with the Nurocor Clinical Platform.